AllStar Health Brands Inc., a Subsidiary of AXXE, Announces Purchase Order (PO) for 25,000 Units of New TapouT Extreme Muscle...
05 February 2014 - 12:00AM
Marketwired
AllStar Health Brands Inc., a Subsidiary of AXXE, Announces
Purchase Order (PO) for 25,000 Units of New TapouT Extreme Muscle
and TapouT Muscle Recovery Supplements
TORONTO, ON--(Marketwired - Feb 4, 2014) - Axxess Pharma Inc.
(PINKSHEETS: AXXE) a specialty pharmaceutical and nutritional
supplements company is pleased to announce Private Label
Nutraceuticals, a Premium manufacturer of nutritional supplements,
based in Norcross, Georgia has placed an initial purchase order for
25,000 units of Axxess Pharmas newest product offerings: TapouT
Extreme Muscle Growth and TapouT Muscle Recovery. The purchase
order is through Axxess Pharmas wholly-owned subsidiary, AllStar
Health Brands Inc.
Kevin Harden, Vice-President of Sales for Private Label
Nutraceuticals, stated: "As an industry leading contract
manufacturer of high-quality supplements, we are truly excited to
work with a primary distributor in the sport nutrition realm.
Because of TapouT's unwavering dedication to superior, innovative
product, as well as extensive experience in the e-commerce arena,
we are honored to have been chosen as their primary contract
manufacturer, and look forward to supporting the growth of their
supplement business. Kevin further stated: "We are thrilled to
start manufacturing these two powerful, natural, muscle growth and
recovery supplements under the TapouT brand. We have worked with
Axxess to develop the optimal formula for performance and recovery,
and expect these products to do extremely well."
Daniel Bagi, M.D. President of Axxess, further stated, "We
believe these new products offer the best ingredients for athletes
and the lay person who works out regularly to maximize their
workout regimens and also recover quickly enough to keep their
workout schedules intact. AllStar anticipates this first order to
sell out Q1 2014, adding close to $1 million in revenues. "
AllStar expects to launch these new products later this month,
through both online and retail channels.
About Private Label Nutraceuticals: Private Label Nutraceuticals
is an industry leader in supplement manufacturing, assisting our
clients in each step of developing their brand, from concept to
distribution. Tracking the latest industry trends allows us to
offer an extensive list of stock products, available either as our
in-house brand or labeled with your brand. Private Label
Nutraceuticals can also formulate custom products to meet the
specific needs of our clients. Our comprehensive services also
include custom formulation development, quality control testing,
graphic design support, packaging procurement and label creation,
marketing support, and both domestic and international fulfillment
services. For more info, please call, email, or visit us at
http://www.PrivateLabelNutra.com.
About Axxess Pharma Inc.:
Axxess Pharma Inc. is a Nevada Corporation operating through its
wholly-owned Canadian Subsidiary: Axxess Pharma Canada Inc.,
headquartered in Toronto. Axxess is a specialty Health Care
Products Company dedicated to improving health and quality of life
by offering select medicines, nutritional supplements and over the
counter remedies all across the Americas. Axxess's goal is to bring
additional products to the market and provide new, innovative
options for better health spanning areas such as high cholesterol,
blood pressure, acute pain, to optimal health management through
improved nutritional supplements.
For more information, please visit www.axxesspharmainc.com, or
contact Investor Relations at (973) 351-3868.
Safe Harbor Statement
Statements about the Company's future expectations and all other
statements in this press release other than historical facts, are
"forward-looking statements" within the meaning of Section 27A of
the Securities Act of 1933, Section 21E of the Securities Exchange
Act of 1934, and as that term is defined in the Private Securities
Litigation Reform Act of 1995. The Company intends that such
forward-looking statements be subject to the safe harbors created
thereby.
The above information contains information relating to the
Company that is based on the beliefs of the Company and/or its
management, as well as assumptions made by any information
currently available to the Company or its management. When used in
this document, the words "anticipate," "estimate," "expect,"
"intend," "plans," "projects," and similar expressions, as they
relate to the Company or its management, are intended to identify
forward-looking statements. Such statements reflect the current
view of the Company regarding future events and are subject to
certain risks, uncertainties and assumptions, including the risks
and uncertainties noted. Should one or more of these risks or
uncertainties materialize, or should underlying assumptions prove
to be incorrect, actual results may vary materially from those
described herein as anticipated, believed, estimated, expected,
intended or projected. In each instance, forward-looking
information should be considered in light of the accompanying
meaningful cautionary statements herein. Factors that could cause
results to differ include, but are not limited to, successful
performance of internal plans, the impact of competitive services
and pricing and general economic risks and uncertainties.
Contact: Investor Relations Taylor Capitol, Inc. Stephen Taylor
(973) 351-3868 staylor@TheStockAlerts.com
www.TheStockAlerts.com
Allstar Health Brands (PK) (USOTC:ALST)
Historical Stock Chart
From Jun 2024 to Jul 2024
Allstar Health Brands (PK) (USOTC:ALST)
Historical Stock Chart
From Jul 2023 to Jul 2024